Status:
COMPLETED
Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Study to evaluate efficacy and tolerability of Micardis® plus under usual daily-practice prescribing-conditions
Eligibility Criteria
Inclusion
- Adult (Age \>= 18 years) males and females for whom a medical antihypertensive therapy is indicated
Exclusion
- Age \< 18 years
Key Trial Info
Start Date :
June 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
8135 Patients enrolled
Trial Details
Trial ID
NCT02238275
Start Date
June 1 2002
Last Update
September 12 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.